Subscribe To

Price Alert Latest News Economic Calendar News

KPRX / Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference

Salt Lake City, Utah--(Newsfile Corp. - February 8, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today that Brian M. Strem, Ph.D, President and CEO of Kiora, will present a Company overview at the BIO CEO & Investor Conference on February 15th at 10:30AM Eastern. The conference will be held at the Marriott Marquis in New York City from February 14th until February 17th.Kiora's presentation will be available for download from... Read More

Demo Live Account See Partner Details

Content Topics

Yumanity

Therapeutics

Inc

Ymtx

Pharmaceuticals

Announces

Participation

Investor

Conference

Stock

KPRX

Posted: Feb 8 2022, 06:45

Author Name: Newsfile Corp

KPRX News

By Newsfile Corp
October 16, 2023

Kiora Pharmaceuticals to Participate in the Lytham Partners Fall 2023 Investor Conference

Encinitas, California--(Newsfile Corp. - October 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online prese

By Newsfile Corp
September 14, 2023

Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa

Encinitas, California--(Newsfile Corp. - September 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that r

By InvestorPlace
August 23, 2023

Why Is Kiora Pharmaceuticals (KPRX) Stock Up 11% Today?

Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is getting a boost on Wednesday after the company revealed new patents in the U.S. and Europe. According t

By InvestorPlace
July 21, 2023

Why Is Kiora Pharmaceuticals (KPRX) Stock Down 7% Today?

Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is dropping on Friday after the clinical-stage pharmaceutical company received a delisting notice. That d

By InvestorPlace
June 2, 2023

Why Is Kiora Pharmaceuticals (KPRX) Stock Down 49% Today?

Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is falling hard on Friday after the company revealed details of a public share offering. The offering has

By Pulse2
February 8, 2023

KPRX Stock: 38.7% Surge Explanation

The stock price of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged by 38.7% in the most recent trading session. This is why.

By InvestorPlace
February 7, 2023

Why Is Kiora Pharmaceuticals (KPRX) Stock Up 61% Today?

Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is heading higher on Tuesday thanks to an update on its KIO-101 eye drops. The big news here is the treatm

By Newsfile Corp
February 8, 2022

Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference

Salt Lake City, Utah--(Newsfile Corp. - February 8, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today tha

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.